Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Bimzelx was approved for the treatment of moderate or severe plaque psoriasis ... if it’s OK to use deodorant or antiperspirant. Scalp psoriasis is a common skin disorder.

Scalp eczema and psoriasis may both cause a dry, itchy rash on the scalp. However, several factors differentiate the two, including the rash appearance, level of itchiness, and causes. A clinical ...

Discover a recent study that has investigated the efficacy of excimer light and topical methotrexate 1% hydrogel in managing ...

A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.

Deucravacitinib significantly improved skin-related quality of life of patients with moderate to severe plaque psoriasis, ...

AX-158 has achieved clinical validation through its phase 2a trial for the treatment of patients with mild to moderate plaque ...

The following is a summary of “Bimekizumab efficacy and safety through 3 years in patients with moderate to severe plaque ...

A 28-week study evaluated the real-world effectiveness of tildrakizumab, an anti–IL-23 biologic approved for patients with moderate to severe psoriasis ... patients with scalp and nail ...